<i>TCL1</i> targeting <i>miR-3676</i> is codeleted with tumor protein p53 in chronic lymphocytic leukemia

Veronica Balatti, Lara Rizzotto, Cecelia Miller, +12

Proceedings of the National Academy of Sciences

The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib

Adam S. Kittai, Cecelia Miller, Daniel Goldstein, +11

Blood

Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib

Cecelia Miller, Amy S. Ruppert, Nyla A. Heerema, +20

Blood Advances

Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL

Jennifer A. Woyach, Gabriela Perez Burbano, Amy S. Ruppert, +29

Blood

Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study

Adam S. Kittai, David A. Bond, Ying Huang, +29

Journal of Clinical Oncology

The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia

Cecelia Miller, Amy S. Ruppert, Sydney Fobare, +14

Oncotarget

Disease-associated mosaic variation in clinical exome sequencing: a two-year pediatric tertiary care experience

Cecelia Miller, Kristy Lee, Ruthann Pfau, +17

Molecular Case Studies

Exome SequencingGeneticsGenetic EpidemiologyGynecologyPathology +14

Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib

Adam S. Kittai, Ying Huang, Kyle A. Beckwith, +9

American Journal of Hematology

Genetic Characterization of Pediatric Sarcomas by Targeted RNA Sequencing

Matthew R. Avenarius, Cecelia Miller, Michael Arnold, +9

Journal of Molecular Diagnostics

Tumor HeterogeneityNext-generation SequencingGeneticsCancer GenomicsGenomics +2

Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes

Jonathan Hyak, Ying Huang, Kerry A. Rogers, +7

Blood Advances

Hematological MalignancyOncologyNovel TherapyMedicineMalignant Blood Disorder +8